Grand Circle Cruise Line Named #1 Best Cruise Line for Solo Travelers in 2024 USA Today 10 Best Awards
Also wins Best River Cruise Line honors BOSTON, Feb. 16, 2024 /PRNewswire/ — Grand Circle Cruise Line has earned the coveted title of #1 Best Cruise Line for Solo Travelers in the 2024 USA Today 10Best Readers’ Choice Awards. The company was nominated by a panel of relevant experts—inc
XanEdu Announces the Release of Unlocking the Potential for Student Success
LIVONIA, Mich., Feb. 16, 2024 /PRNewswire/ — XanEdu, a custom publishing company working with the higher education and K-12 markets and a part of the Scholarus learning portfolio of companies, has announced the release of a new textbook, Unlocking the Potential for Student Success, authored by
Dr. Yorell Manon-Matos Scholarship for Healthcare Students: A Beacon of Opportunity for Aspiring Healthcare Professionals
DAKOTA DUNES, S.D., Feb. 16, 2024 /PRNewswire/ — The esteemed Dr. Yorell Manon-Matos Scholarship for Healthcare Students announces its inaugural offering, providing a transformative opportunity for undergraduate and graduate students pursuing careers in healthcare. Established by renowned han
Music Licensing, Inc. Highlights Milestones and Market Impact in 2023 Year-End Audit
NAPLES, Fla., Feb. 16, 2024 /PRNewswire/ — Music Licensing, Inc. (OTC: SONG), operating under the brand Pro Music Rights, proudly announces significant achievements and market impact as revealed in its 2023 year-end audit, scheduled for completion today. As the fifth public performance rights
MAISON SOLUTIONS INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Maison Solutions To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $25,000 investing in Maison Solutions (a) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s October 2023 initial public of
United States Ammonia Crackers Industry Research Report 2023: Ammonia Crackers Supporting Fuel Cell Technology Advancements in the U.S. – Forecasts to 2032
DUBLIN, Feb. 16, 2024 /PRNewswire/ — The “U.S. Ammonia Crackers Market – Analysis and Forecast, 2023-2032” report has been added to ResearchAndMarkets.com’s offering. The U.S. ammonia crackers market is projected to reach $247.98 million by 2032 from $26.14 million i
Capsulyte Unveils PREGAME: The Ultimate Solution for Party Recovery, Marking Its Debut at DC Fashion Week
Capsulyte PREGAME, a doctor formulated supplement to aid alcohol recovery, launches at DC Fashion Week as the hangover recovery market is set to grow over the next decade. CRANBURY, N.J., Feb. 16, 2024 /PRNewswire/ — Capitalizing on cutting-edge ingredients, Capsulyte’s PREGAME has emer
OCCUPATIONAL HEALTH PHYSICIAN URGES CHICAGOANS TO WEAR MASKS/GET VACCINATED
Dr. David Fletcher, Public Health Expert Illinois says only 20 percent of adults are vaccinated CHICAGO, Feb. 16, 2024 /PRNewswire/ — With more people back at work and in close quarters, the Centers for Disease Control (CDC) is urging patients to continue taking precautions for COVID-19 and n
Martians Wanted: NASA Opens Call for Simulated Yearlong Mars Mission
WASHINGTON, Feb. 16, 2024 /PRNewswire/ — NASA is seeking applicants to participate in its next simulated one-year Mars surface mission to help inform the agency’s plans for human exploration of the Red Planet. The second of three planned ground-based missions called CHAPEA (Crew Health
FDA approves Xolair® (omalizumab) as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placebo Mor
